|
|
||||||||
J Thorac Cardiovasc Surg 2008;135:1322-1326
© 2008 The American Association for Thoracic Surgery
Evolving Technology |
a Department of Cardiothoracic Surgery, University of Vienna, Vienna, Austria
b Department of Cardiology, University Hospital Rostock, Rostock, Germany
c Department of Radiology, Centre Hospitalier Universitaire, Hopital de Rangueil, Toulouse, France
d Radiologie Vasculaire, Hopital Cardiologique CHRU de Lille, Lille, France
e Centre Hospitalier Universitaire, Hopital Sainte Marguerite, Marseille, France
f Department of Cardiothoracic Surgery, St Antonius Hospital, Nieuwagein, The Netherlands
g Centre Hospitalier Universitaire, Hopital de la Timone, Marseille, France
h Department of Internal Medicine, University of Vienna, Vienna, Austria
i Cardiovascular Radiology, University Hospital S. Orsola, Bologna, Italy
Received for publication May 28, 2007; revisions received September 2, 2007; accepted for publication September 12, 2007. * Address for reprints: Rossella Fattori, MD, Department of Radiology-Cardiovascular Unit, University Hospital S. Orsola, Via Masseranti 9, 40128 Bologna, Italy. (Email: rosella.fattori{at}unibo.it).
Objective: Predictors of late conversion to conventional surgery after thoracic endovascular stent-graft placement are currently unknown.
Methods: We analyzed data from 422 of 457 consecutive patients who underwent endovascular thoracic repair with the Medtronic Talent thoracic stent-graft (Medtronic/AVE, Santa Rosa, Calif). Of these, 16 patients (3.8%) required late conversion to open surgery during a median follow-up interval of 17 months (range 7–33 months). Six of these patients had undergone previous aortic surgery, 3 patients had previous cardiac surgery, and 5 patients had Marfan syndrome. In patients with late conversion, indications for primary stent-graft placement were dissection in 10 patients, degenerative aneurysm in 5 patients, and penetrating ulcer in 1 patient.
Results: By multivariable Cox analysis, Marfan syndrome (adjusted hazard ratio 9.97, P = .008), type I endoleak (adjusted hazard ratio 3.99, P = .012), the use of more than 1 stent-graft (adjusted hazard ratio 3.89, P = .018), and procedural complications (adjusted hazard ratio 17.50, P = .003) were independent predictors of late conversion.
Conclusion: Endovascular treatment for thoracic aortic disease with the Talent stent-graft is associated with a relatively low rate of late conversion to conventional surgery. Better results may be achieved by excluding patients with Marfan syndrome for such a procedure and early aggressive treatment of early type I endoleaks.
This article has been cited by other articles:
![]() |
L. Canaud, P. Alric, T. Gandet, B. Albat, C. Marty-Ane, and J.-P. Berthet Surgical conversion after thoracic endovascular aortic repair J. Thorac. Cardiovasc. Surg., November 1, 2011; 142(5): 1027 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Garbade, M. Jenniches, M. A. Borger, M. J. Barten, D. Scheinert, M. Gutberlet, T. Walther, and F.-W. Mohr Outcome of patients suffering from acute type B aortic dissection: a retrospective single-centre analysis of 135 consecutive patients Eur J Cardiothorac Surg, September 1, 2010; 38(3): 285 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cheng, J. Martin, H. Shennib, J. Dunning, C. Muneretto, S. Schueler, L. Von Segesser, P. Sergeant, and M. Turina Endovascular Aortic Repair Versus Open Surgical Repair for Descending Thoracic Aortic Disease: A Systematic Review and Meta-Analysis of Comparative Studies J. Am. Coll. Cardiol., March 9, 2010; 55(10): 986 - 1001. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |